Canada - Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry
Since 2014, Canada Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry increased 2.3% year on year. In 2019, the country was number 17 comparing other countries in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry at $420,159,373.17 Million PPP. Canada is overtaken by Hungary, which was ranked number 16 with $426,636,826.27 Million PPP and is followed by Ireland with $407,799,563.58 Million PPP. United States topped the ranking with $70,565,318,932.39 Million PPP in 2019, that is a growth of 3.3% versus 2018. China, Japan and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland witnessed the best average annual growth at +43.9% per year, while Lithuania was the worst growing country at -42.6% per year.
Loading...
Date | Million US Dollars PPP |
---|---|
2019 | 420,159,373.17 |
2018 | 427,220,978.12 |
2017 | 455,701,557.85 |
2016 | 410,992,641.87 |
2015 | 400,639,663.21 |
How does Canada rank in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry?
# | 69 Countries | Million US Dollars PPP | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
United States
|
70,565,318,932.39 | 2019 | +3.3 % | +4.5 % | View data | |
2 |
#2
China
|
13,956,388,273.35 | 2019 | +4.5 % | +6.1 % | View data | |
16 |
#16
Hungary
|
426,636,826.27 | 2019 | +1.7 % | -0.3 % | View data | |
17 |
#17
Canada
|
420,159,373.17 | 2019 | -1.6 % | +2.3 % | View data | |
18 |
#18
Ireland
|
407,799,563.58 | 2019 | +3.8 % | +16.9 % | View data |